Many studies have indicated beneficial effects of SCFAs, specifically, acetate, propionate, and butyrate, on energy homeostasis and metabolism, and their crucial role in preventing HFD-induced obesity and improving insulin sensitivity [82,83,84]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.